Atlas Trials

Von Hippel-Lindau Syndrome

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Von Hippel-Lindau Syndrome

RecordFirmDate
68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors (NCT03001349)M.D. Anderson Cancer Center2017-05-16
A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab (NCT02859441)National Eye Institute (NEI)2017-01-23
Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors (NCT01967537)National Cancer Institute (NCI)2013-10-18
TKI 258 in Von Hippel-Lindau Syndrome (VHL) (NCT01266070)M.D. Anderson Cancer Center2012-11-01
National Eye Institute Biorepository for Retinal Diseases (NCT01496625)National Eye Institute (NEI)2012-06-18
Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome (NCT00673816)National Eye Institute (NEI)2008-05-01
Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow (NCT00330564)M.D. Anderson Cancer Center2006-05-01
Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome (NCT00089765)National Eye Institute (NEI)2004-08-10
Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome (NCT00075348)National Institutes of Health Clinical Center (CC)2003-12-01

Track Von Hippel-Lindau Syndrome automatically

Every clearance here is in the API, with alerts when new ones post.